[go: up one dir, main page]

ZA200203100B - A salt of morphine. - Google Patents

A salt of morphine.

Info

Publication number
ZA200203100B
ZA200203100B ZA200203100A ZA200203100A ZA200203100B ZA 200203100 B ZA200203100 B ZA 200203100B ZA 200203100 A ZA200203100 A ZA 200203100A ZA 200203100 A ZA200203100 A ZA 200203100A ZA 200203100 B ZA200203100 B ZA 200203100B
Authority
ZA
South Africa
Prior art keywords
morphine
salt
Prior art date
Application number
ZA200203100A
Other languages
English (en)
Inventor
Lisbeth Illum
Peter Watts
Alan Smith
Ian Lafferty
Original Assignee
West Pharm Serv Drug Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West Pharm Serv Drug Res Ltd filed Critical West Pharm Serv Drug Res Ltd
Publication of ZA200203100B publication Critical patent/ZA200203100B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200203100A 1999-10-20 2002-04-18 A salt of morphine. ZA200203100B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9924797.5A GB9924797D0 (en) 1999-10-20 1999-10-20 Compound

Publications (1)

Publication Number Publication Date
ZA200203100B true ZA200203100B (en) 2003-09-23

Family

ID=10863040

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200203100A ZA200203100B (en) 1999-10-20 2002-04-18 A salt of morphine.

Country Status (15)

Country Link
US (1) US6387917B1 (fr)
EP (1) EP1224188B1 (fr)
JP (1) JP4928037B2 (fr)
AU (1) AU771616B2 (fr)
CA (1) CA2388395C (fr)
CY (1) CY1106352T1 (fr)
DE (1) DE60033044T2 (fr)
DK (1) DK1224188T3 (fr)
ES (1) ES2282141T3 (fr)
GB (1) GB9924797D0 (fr)
NO (1) NO327145B1 (fr)
NZ (1) NZ518481A (fr)
PT (1) PT1224188E (fr)
WO (1) WO2001029046A2 (fr)
ZA (1) ZA200203100B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9707934D0 (en) * 1997-04-18 1997-06-04 Danbiosyst Uk Improved delivery of drugs to mucosal surfaces
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
WO2004003145A2 (fr) * 2002-06-28 2004-01-08 Nastech Pharmaceutical Company Inc. Compositions et methodes permettant de moduler la physiologie de molecules d'adhesion jonctionnelle epitheliale en vue d'ameliorer l'administration de composes therapeutiques par voie muqueuse
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
GB0300531D0 (en) * 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
EP1622448A2 (fr) * 2003-05-01 2006-02-08 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Administration nasale de leuprolide analogue lh-rh
GB0315632D0 (en) * 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
US20050129679A1 (en) 2003-12-15 2005-06-16 Nastech Pharmaceutical Company Inc. Method for opening tight junctions
US20050175679A1 (en) * 2004-02-10 2005-08-11 Michael Moshman Controlled release formulations
SG194927A1 (en) 2011-05-13 2013-12-30 Euro Celtique Sa Intranasal pharmaceutical dosage forms comprising naloxone
WO2014140899A2 (fr) 2013-03-15 2014-09-18 Johnson Matthey Public Limited Company Solvate méthanolique de sulfate de morphine, son processus de fabrication et ses compositions et procédés associés destinés au traitement de la douleur

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB343397A (en) * 1929-05-24 1931-02-19 Chem Fab Vormals Sandoz Process for the manufacture of easily soluble salts of benzyl morphine
US2665227A (en) 1950-06-30 1954-01-05 Nat Res Corp Apparatus and method of coating by vapor deposition
CH407120A (de) * 1961-03-06 1966-02-15 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen Piperidinderivaten
DE1445518A1 (de) * 1964-01-24 1968-12-05 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen Halogenallylpiperidinen
US4334071A (en) * 1981-02-02 1982-06-08 Miles Laboratories, Inc. 17-Cyclobutylmethyl-3-hydroxy-8β-methyl-6-methylene-morphinane methanesulfonate
US4464378A (en) 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
DK0689438T3 (da) * 1993-03-26 2003-09-29 Franciscus Wilhelmus He Merkus Farmaceutiske præparater til intranasal administration af apomorfin
DE69324476T2 (de) 1993-05-03 1999-09-02 Physion S.R.L. Neue Morphinzusammensetzungen für iontophoretische Verabreichung
US5607940A (en) 1994-07-18 1997-03-04 Stephen; Robert L. Morphine formulations for use by electromotive administration
GB9416884D0 (en) * 1994-08-20 1994-10-12 Danbiosyst Uk Drug delivery compositions
JPH09208465A (ja) 1996-02-07 1997-08-12 Takeda Chem Ind Ltd 高濃度注射用モルヒネ液
GB9700624D0 (en) * 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
DE19834005A1 (de) * 1997-09-25 1999-04-01 Lohmann Therapie Syst Lts Säureadditionssalze von Morphin-Alkaloiden und deren Verwendung
IL134787A (en) 1997-09-25 2007-05-15 Lohmann Therapie Syst Lts Acid addition salts of morphine alkaloids, their preparation and pharmaceutical compositions containing them for trandermal and transmucosal application
WO2000076477A1 (fr) 1999-06-16 2000-12-21 Nastech Pharmaceutical Co., Inc. Methodes et compositions permettant de traiter la douleur incidente
US6225343B1 (en) 1999-06-16 2001-05-01 Nastech Pharmaceutical Company, Inc. Compositions and methods comprising morphine gluconate
AU6046900A (en) 1999-06-16 2001-01-02 Nastech Pharmaceutical Company, Inc Method for increasing the solubility of morphine and pharmaceutical compositionsprepared therefrom
JP2003501467A (ja) 1999-06-16 2003-01-14 ナステック・ファーマシューティカル・カンパニー・インコーポレーテッド 鼻内モルヒネを含む医薬用製剤および方法

Also Published As

Publication number Publication date
NZ518481A (en) 2004-10-29
AU771616B2 (en) 2004-04-01
DK1224188T3 (da) 2007-04-02
US6387917B1 (en) 2002-05-14
JP4928037B2 (ja) 2012-05-09
NO20021815L (no) 2002-06-14
JP2003512380A (ja) 2003-04-02
EP1224188A2 (fr) 2002-07-24
DE60033044D1 (de) 2007-03-08
WO2001029046A3 (fr) 2001-11-01
ES2282141T3 (es) 2007-10-16
NO327145B1 (no) 2009-05-04
AU7933500A (en) 2001-04-30
CA2388395A1 (fr) 2001-04-26
DE60033044T2 (de) 2007-10-18
NO20021815D0 (no) 2002-04-17
PT1224188E (pt) 2007-02-28
CA2388395C (fr) 2010-03-09
WO2001029046A2 (fr) 2001-04-26
EP1224188B1 (fr) 2007-01-17
CY1106352T1 (el) 2011-10-12
GB9924797D0 (en) 1999-12-22

Similar Documents

Publication Publication Date Title
TW389159U (en) Compound perforator
AU7813300A (en) A viscera retainer
IL159332A0 (en) A knowledge-engineering protocol-suite
SG109439A1 (en) Sulfonium salt compounds
AU142007S (en) A cafetiere
ZA200203100B (en) A salt of morphine.
ZA984085B (en) A novel salt.
GB9915720D0 (en) A receiver
ZA984486B (en) A new salt
GB2357389B (en) Telemetry systems
PL349775A1 (en) New morpholinobenzamide salts
GB9917074D0 (en) A wellhead arrangement
GB9917344D0 (en) Novel salt
GB2350953B (en) A receiver
AU139849S (en) A bracelet
AU142049S (en) A frypan
AU139889S (en) A screwspike
AU140789S (en) A wallhanging
AU140251S (en) A bidette
AU140877S (en) A frypan
GB9923771D0 (en) A powerfeed
GB9921309D0 (en) A pentapod
GB9910695D0 (en) A hairband
AU137662S (en) A barstool
AU139850S (en) A necklace